| 1 | [SID7971145] | Active | Potency | 2.5929 | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. [AID624296, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | Potency | 2.5929 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | | AID | 624296 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 2 | [SID7971145] | Active | Potency | 2.9093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | Potency | 2.9093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 3 | [SID7971145] | Active | Potency | 2.9093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | Potency | 2.9093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 4 | [SID7971145] | Active | Potency | 2.9093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | Potency | 2.9093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID7971145] | Active | Potency | 10.3225 | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | Potency | 10.3225 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 6 | [SID7971145] | Active | | | High throughput fluorescence polarization-based assay to screen for small molecule inhibitors of the Polo box domain (PBD) of Plk1. [AID693, Type: screening] | serine/threonine-protein kinase PLK1 [Homo sapiens] [gi:21359873] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | High throughput fluorescence polarization-based assay to screen for small molecule inhibitors of the Polo box domain (PBD) of Plk1. | | AID | 693 | | BioAssay type | screening | | Target | serine/threonine-protein kinase PLK1 [Homo sapiens] [gi:21359873] | | PubMed | | | Data Table |  |
|
| 7 | [SID7971145] | Active | | | High throughput fluorescence polarization-based assay to screen for small molecule inhibitors of the Polo box domain (PBD) of Plk1. [AID693, Type: screening] | serine/threonine-protein kinase PLK1 [Homo sapiens] [gi:21359873] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | High throughput fluorescence polarization-based assay to screen for small molecule inhibitors of the Polo box domain (PBD) of Plk1. | | AID | 693 | | BioAssay type | screening | | Target | serine/threonine-protein kinase PLK1 [Homo sapiens] [gi:21359873] | | PubMed | | | Data Table |  |
|
| 8 | [SID7971145] | Active | | | HCS assay for microtubule stabilizers [AID2205, Type: screening] | tubulin, beta [Homo sapiens] [gi:29788785] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | HCS assay for microtubule stabilizers | | AID | 2205 | | BioAssay type | screening | | Target | tubulin, beta [Homo sapiens] [gi:29788785] | | PubMed | | | Data Table |  |
|
| 9 | [SID7971145] | Active | | | HCS assay for microtubule stabilizers [AID2205, Type: screening] | tubulin, beta [Homo sapiens] [gi:29788785] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | HCS assay for microtubule stabilizers | | AID | 2205 | | BioAssay type | screening | | Target | tubulin, beta [Homo sapiens] [gi:29788785] | | PubMed | | | Data Table |  |
|
| 10 | [SID7971145] | Active | | | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F [AID1446, Type: screening] | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F | | AID | 1446 | | BioAssay type | screening | | Target | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] | | PubMed | | | Data Table |  |
|
| 11 | [SID7971145] | Active | | | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F [AID1446, Type: screening] | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F | | AID | 1446 | | BioAssay type | screening | | Target | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] | | PubMed | | | Data Table |  |
|
| 12 | [SID7971145] | Active | | | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F [AID1446, Type: screening] | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F | | AID | 1446 | | BioAssay type | screening | | Target | Janus kinase 2 (a protein tyrosine kinase) [Homo sapiens] [gi:119579178] | | PubMed | | | Data Table |  |
|
| 13 | [SID7971145] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 14 | [SID7971145] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 15 | [SID7971145] | Active | | | Dose-response cell-based assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) [AID681, Type: confirmatory] | Nuclear receptor ROR-alpha [gi:548814] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Dose-response cell-based assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) | | AID | 681 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-alpha [gi:548814] | | PubMed | | | Data Table |  |
|
| 16 | [SID7971145] | Active | | | Dose-response cell-based assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) [AID681, Type: confirmatory] | Nuclear receptor ROR-alpha [gi:548814] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Dose-response cell-based assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) | | AID | 681 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-alpha [gi:548814] | | PubMed | | | Data Table |  |
|
| 17 | [SID7971145] | Active | | | Dose-response cell-based assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) [AID681, Type: confirmatory] | Nuclear receptor ROR-alpha [gi:548814] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Dose-response cell-based assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) | | AID | 681 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-alpha [gi:548814] | | PubMed | | | Data Table |  |
|
| 18 | [SID7971145] | Active | | | Dose-response cell-based assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) [AID681, Type: confirmatory] | Nuclear receptor ROR-alpha [gi:548814] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Dose-response cell-based assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) | | AID | 681 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-alpha [gi:548814] | | PubMed | | | Data Table |  |
|
| 19 | [SID7971145] | Active | | | Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) [AID560, Type: screening] | Nuclear receptor ROR-alpha [gi:548814] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) | | AID | 560 | | BioAssay type | screening | | Target | Nuclear receptor ROR-alpha [gi:548814] | | PubMed | | | Data Table |  |
|
| 20 | [SID7971145] | Active | | | Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) [AID560, Type: screening] | Nuclear receptor ROR-alpha [gi:548814] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) | | AID | 560 | | BioAssay type | screening | | Target | Nuclear receptor ROR-alpha [gi:548814] | | PubMed | | | Data Table |  |
|
| 21 | [SID7971145] | Active | | | Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) [AID560, Type: screening] | Nuclear receptor ROR-alpha [gi:548814] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) | | AID | 560 | | BioAssay type | screening | | Target | Nuclear receptor ROR-alpha [gi:548814] | | PubMed | | | Data Table |  |
|
| 22 | [SID7971145] | Active | | | Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) [AID560, Type: screening] | Nuclear receptor ROR-alpha [gi:548814] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) | | AID | 560 | | BioAssay type | screening | | Target | Nuclear receptor ROR-alpha [gi:548814] | | PubMed | | | Data Table |  |
|
| 23 | [SID7971145] | Active | | | Cell Proliferation & Viability (Cytotoxicity) Primary Assay 60K MLSMR [AID463, Type: screening] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Cell Proliferation & Viability (Cytotoxicity) Primary Assay 60K MLSMR | | AID | 463 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID7971145] | Active | | | Cell Proliferation & Viability (Cytotoxicity) Dose Response Assay 60K MLSMR [AID464, Type: confirmatory] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Cell Proliferation & Viability (Cytotoxicity) Dose Response Assay 60K MLSMR | | AID | 464 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID7971145] | Active | EC50 | | Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7 cells) [AID430, Type: confirmatory] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | EC50 | [uM] | | BioAssay | Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7 cells) | | AID | 430 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID7971145] | Active | | | Human H69AR Lung Tumor Cell Growth Inhibition Assay - 86K Screen [AID598, Type: screening] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Human H69AR Lung Tumor Cell Growth Inhibition Assay - 86K Screen | | AID | 598 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID7971145] | Active | | | Discovery of Novel Allosteric Modulators of the M1 Muscarinic Receptor: Agonist Primary Screen [AID626, Type: screening] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Discovery of Novel Allosteric Modulators of the M1 Muscarinic Receptor: Agonist Primary Screen | | AID | 626 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID7971145] | Active | | | Allosteric Modulators of D1 Receptors: Primary Screen [AID641, Type: screening] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Allosteric Modulators of D1 Receptors: Primary Screen | | AID | 641 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID7971145] | Active | | | Allosteric Modulators of D1 Receptors: Confirmation Screen [AID642, Type: other] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Allosteric Modulators of D1 Receptors: Confirmation Screen | | AID | 642 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID7971145] | Active | | | Allosteric Modulators of D1 Receptors: Secondary Assay 2 [AID647, Type: other] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Allosteric Modulators of D1 Receptors: Secondary Assay 2 | | AID | 647 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID7971145] | Active | | | Human Endothelial Cell Proliferation Assay in 384-well format [AID648, Type: screening] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Human Endothelial Cell Proliferation Assay in 384-well format | | AID | 648 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID7971145] | Active | | | High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression - Pilot Screen [AID823, Type: screening] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression - Pilot Screen | | AID | 823 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID7971145] | Active | | | High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor - Pilot Screen [AID824, Type: screening] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor - Pilot Screen | | AID | 824 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID7971145] | Active | | | Human Lung Fibroblast Proliferation Assay [AID719, Type: screening] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Human Lung Fibroblast Proliferation Assay | | AID | 719 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID7971145] | Active | | | Counterscreen for inhibitors of Janus kinase 2 mutant JAK2V617F: Cell-based high throughput assay to identify inhibitors of parental Ba/F3 cell viability. [AID1486, Type: screening] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of Janus kinase 2 mutant JAK2V617F: Cell-based high throughput assay to identify inhibitors of parental Ba/F3 cell viability. | | AID | 1486 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID7971145] | Active | | | Luminescence-based confirmation cell-based assay for cytotoxic compounds using the IEC-6 intestinal epithelial cell line. [AID1907, Type: screening] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Luminescence-based confirmation cell-based assay for cytotoxic compounds using the IEC-6 intestinal epithelial cell line. | | AID | 1907 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID7971145] | Active | | | Profiling the NIH Molecular Libraries Small Molecule Repository: Autofluorescence at 339/460 nm [AID709, Type: screening] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Profiling the NIH Molecular Libraries Small Molecule Repository: Autofluorescence at 339/460 nm | | AID | 709 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID7971145] | Active | | | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators [AID1814, Type: screening] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators | | AID | 1814 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID7971145] | Active | | | Luminescence-based counterscreen assay for KLF5 inhibitors: cell-based high throughput screening assay to identify cytotoxic compounds using the IEC-6 intestinal epithelial cell line. [AID1825, Type: screening] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Luminescence-based counterscreen assay for KLF5 inhibitors: cell-based high throughput screening assay to identify cytotoxic compounds using the IEC-6 intestinal epithelial cell line. | | AID | 1825 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID7971145] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Full-Length Luciferase Counterscreen assay [AID504607, Type: screening] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Full-Length Luciferase Counterscreen assay | | AID | 504607 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID7971145] | Active | | | HIV-1 RT-RNase H MLSCN HTS MH077605 [AID565, Type: screening] | Chain A, Hiv-1 Reverse Transcriptase Mol_id: 1; Molecule: Hiv-1 Reverse Transcriptase; Chain: A, B; [gi:1431733] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | HIV-1 RT-RNase H MLSCN HTS MH077605 | | AID | 565 | | BioAssay type | screening | | Target | Chain A, Hiv-1 Reverse Transcriptase Mol_id: 1; Molecule: Hiv-1 Reverse Transcriptase; Chain: A, B; [gi:1431733] | | PubMed | | | Data Table |  |
|
| 42 | [SID7971145] | Active | IC50 | | High Throughput Imaging Assay for Beta-Catenin [AID1665, Type: confirmatory] | catenin beta-1 [Homo sapiens] [gi:4503131] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | IC50 | [uM] | | BioAssay | High Throughput Imaging Assay for Beta-Catenin | | AID | 1665 | | BioAssay type | confirmatory | | Target | catenin beta-1 [Homo sapiens] [gi:4503131] | | PubMed | | | Data Table |  |
|
| 43 | [SID7971145] | Active | IC50 | | High Throughput Imaging Assay for Beta-Catenin [AID1665, Type: confirmatory] | catenin beta-1 [Homo sapiens] [gi:4503131] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | IC50 | [uM] | | BioAssay | High Throughput Imaging Assay for Beta-Catenin | | AID | 1665 | | BioAssay type | confirmatory | | Target | catenin beta-1 [Homo sapiens] [gi:4503131] | | PubMed | | | Data Table |  |
|
| 44 | [SID7971145] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 45 | [SID7971145] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 46 | [SID7971145] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 47 | [SID7971145] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 48 | [SID7971145] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. [AID504668, Type: screening] | Breast cancer type 1 susceptibility protein [gi:728984] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. | | AID | 504668 | | BioAssay type | screening | | Target | Breast cancer type 1 susceptibility protein [gi:728984] | | PubMed | | | Data Table |  |
|
| 49 | [SID7971145] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. [AID504668, Type: screening] | Breast cancer type 1 susceptibility protein [gi:728984] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. | | AID | 504668 | | BioAssay type | screening | | Target | Breast cancer type 1 susceptibility protein [gi:728984] | | PubMed | | | Data Table |  |
|
| 50 | [SID7971145] | Active | | | HTS for Estrogen Receptor-beta Coactivator Binding inhibitors [AID633, Type: screening] | estrogen receptor beta isoform 1 [Homo sapiens] [gi:10835013] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 7971145 | | CID | 946201 | | Outcome | Active | | BioAssay | HTS for Estrogen Receptor-beta Coactivator Binding inhibitors | | AID | 633 | | BioAssay type | screening | | Target | estrogen receptor beta isoform 1 [Homo sapiens] [gi:10835013] | | PubMed | | | Data Table |  |
|